Clinical Trial Update: To Evaluate the Safety and Efficacy of NVP-2203 Tablet in Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NVP-2203 tablet evaluating safety and efficacy in cardiovascular diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• NVP-2203

Snippet

Sponsor: NVP Healthcare | Conditions: Cardiovascular Diseases | Phase 3 | Status: UNKNOWN